This page contains brief information about alpelisib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Alpelisib is approved to treat:
- Breast cancer that is hormone receptor positive and HER2 negative and has a mutation in the PIK3CA gene. It is used with fulvestrant to treat postmenopausal women, and men, whose breast cancer is advanced or metastatic and has gotten worse during or after treatment with hormone therapy.
Alpelisib is also being studied in the treatment of other types of cancer.
More About Alpelisib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Alpelisib - Check for trials from NCI's list of cancer clinical trials now accepting patients.